Kennedy, Margaret C. http://orcid.org/0000-0001-9106-1906
Lowe, Scott W. http://orcid.org/0000-0002-5284-9650
Funding for this research was provided by:
Geoffrey Beene Cancer Research Center
Howard Hughes Medical Institute
Article History
Received: 1 March 2022
Revised: 16 March 2022
Accepted: 17 March 2022
First Online: 31 March 2022
Competing interests
: SWL is on the scientific advisory board and holds equity in PMV Pharmaceuticals, a biotech company interested in targeting p53 mutants for cancer therapy.